Showing results (1861-1870 of 2,117) with videos related to

Sort By:
Pageof 212
Redox Biology|October 9, 2018
Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney diseaseKranti A Mapuskar, Hsiang Wen, Danniele G Holanda, et al.
Journal of Thrombosis and Haemostasis : JTH|April 15, 2011
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)A Tiede, U Friedrich, C Stenmo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2011
Predictors and risk model development for menopausal age in fragile X premutation carriersMarian A Spath, Ton B Feuth, Arie P T Smits, et al.
Journal of Molecular and Cellular Cardiology|December 4, 2012
Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathwayBenjamin Lauzier, Fanny Vaillant, Clemence Merlen, et al.
Cardiovascular Research|May 7, 2011
Regulation of murine cardiac contractility by activation of α(1A)-adrenergic receptor-operated Ca(2+) entryMarion C Mohl, Siiri E Iismaa, Xiao-Hui Xiao, et al.
Diabetes|November 13, 2015
MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac DysfunctionMatthieu Ruiz, Lise Coderre, Dominic Lachance, et al.
BMC Infectious Diseases|August 21, 2015
High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, CanadaAnn N Burchell, Vanessa G Allen, Sandra L Gardner, et al.
Human Reproduction (Oxford, England)|May 18, 2011
Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersM A Spath, T B Feuth, E G Allen, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2020
Half-life extension of peptidic APJ agonists by N-terminal lipid conjugationAnthony B Reed, Brian A Lanman, Jerry Ryan Holder, et al.
Pageof 212